Fludeoxyglucose F 18 Injection
Product Images NDC 52670-551

2 FDA label images from Mayo Clinic · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F 18 (NDC 52670-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayo Clinic, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fludeoxyglucose F 18 Injection Usp Is Provided As A Ready To Use Sterile, Pyrogen Free, Clear, Colorless Citrate Buffered Solution. Each mL Contains Between 0.740 To 8.88 Gbq (20.0­240 Mci) Of 2-deoxy-2-[18f]fluoro-d-glucose At The Eos, 4.5 mg Of Sodium Chloride In Citrate Buffer. The Ph Of The Solution Is Between 4.5 And 7.5. The Solution Is Packaged In A Multiple-dose Glass Vial And Does Not Contain Any Preservative. Ethanol (3 mg/ml) Is Used As An Antioxidant In Fludeoxyglucose F 18 Injection Usp. (Fludeoxyglucose F 18 Injection 01)

Fludeoxyglucose F 18 Injection Usp Is Provided As A Ready To Use Sterile, Pyrogen Free, Clear, Colorless Citrate Buffered Solution. Each mL Contains Between 0.740 To 8.88 Gbq (20.0­240 Mci) Of 2-deoxy-2-[18f]fluoro-d-glucose At The Eos, 4.5 mg Of Sodium Chloride In Citrate Buffer. The Ph Of The Solution Is Between 4.5 And 7.5. The Solution Is Packaged In A Multiple-dose Glass Vial And Does Not Contain Any Preservative. Ethanol (3 mg/ml) Is Used As An Antioxidant In Fludeoxyglucose F 18 Injection Usp. (Fludeoxyglucose F 18 Injection 01)
Chemical structure of Fludeoxyglucose F-18, showing the molecular arrangement with fluorine-18 labeled at the indicated position. This structure corresponds to the active ingredient in the injection formulation labeled by Mayo Clinic.*
FDA Label Image

Principal Display Panelndc 52670-551-30fludeoxyglucose F 18 Injection, Uspintravenous Userx Only (Fludeoxyglucose F 18 Injection 02)

Principal Display Panelndc 52670-551-30fludeoxyglucose F 18 Injection, Uspintravenous Userx Only (Fludeoxyglucose F 18 Injection 02)
Label for Fludeoxyglucose F 18 Injection, USP, 240 mCi/mL, an intravenous radiopharmaceutical manufactured by Mayo Clinic. The label includes cautions for radioactive material, fields for lot number, EOS date/time, activity, volume, concentration, and expiration date/time, along with storage instructions and radioactive half-life information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.